Next Generation Therapies

Aaron Beck, M.D.
Aaron Beck, M.D.
November 15, 2011
Recent Foundation-funded research led by NARSAD Distinguished Investigator Grantee Aaron Beck, M.D. at the University of Pennsylvania, demonstrates that a...
Allan T. Gulledge, Ph.D. of Dartmouth Medical School
Allan T. Gulledge, Ph.D.
November 15, 2011
The chemicals that act in the brain act in other parts of the body as well─in the heart, in the respiratory system, in muscles. Drugs that affect brain...
Keming Gao, M.D., Ph.D. of Case Medical Center
Keming Gao, M.D., Ph.D.
November 15, 2011
For people with mood disorders such as bipolar disorder or major depressive disorder─complex, heterogeneous illnesses on their own─having other brain and...
Jennifer Gottlieb, Ph.D., NARSAD YI, Dartmouth Medical School
Jennifer Gottlieb, Ph.D.
November 15, 2011
Upwards of half of people taking antipsychotic medications continue to have some symptoms of psychosis. Cognitive behavioral therapy (CBT) is a non-...
Sarah H. Lisanby, M.D., Duke University School of Medicine
Sarah H. Lisanby, M.D.
November 15, 2011
A significant minority of people with depressive illness fail to respond to any currently available antidepressant medication. However, new methods of brain...

Pages

Subscribe to